3rd Quarter - Report — MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY (2008)

Firm

MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Client

MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Income

—

Expenses

$340,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Medicare/Medicaid and other general health issues

Lobbyist	Covered position, as disclosed
MICHAEL J EGING	—
THOMAS JOHN FUSSARO	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill

Lobbyist	Covered position, as disclosed
MICHAEL J EGING	—
THOMAS JOHN FUSSARO	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Health Issues HCR

Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness

Lobbyist	Covered position, as disclosed
MICHAEL J EGING	—
THOMAS JOHN FUSSARO	—

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Budget/Appropriations BUD

House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative Effectiveness LHHS Appropriations Homeland Appropriations Agriculture Appropriations

Lobbyist	Covered position, as disclosed
MICHAEL J EGING	—
THOMAS JOHN FUSSARO	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 H.4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions

Lobbyist	Covered position, as disclosed
MICHAEL J EGING	—
THOMAS JOHN FUSSARO	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE

Bills named: H.R. 6331 (110th), S. 2662 (110th), S. 2029 (110th), S. 3 (110th), H.R. 5480 (110th), S. 3101 (110th)

Pharmacy PHA

H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicine Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics

Lobbyist	Covered position, as disclosed
MICHAEL J EGING	—
THOMAS JOHN FUSSARO	—

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5629 (110th), H.R. 1038 (110th), S. 1505 (110th), S. 623 (110th), H.R. 1956 (110th), S. 2029 (110th), S. 1695 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.